22nd Century Group Inc (XXII)

[nonameface13]

FDA’s Center for Tobacco Products Commemorates 10th Anniversary of Tobacco Control Act

https://www.fda.gov/news-events/fda-voices-perspectives-fda-leadership-and-experts/achievements-tobacco-regulation-over-past-decade-and-beyond?utm_source=Eloqua&utm_medium=email&utm_term=stratcomms&utm_content=blog&utm_campaign=CTP%20News%3A%2010th%20Anniversary%20Blog_Video%20-%2062019

In 2013, the FDA and NIH awarded money to 14 Tobacco Centers of Regulatory Science. These grants fund research on topics critical to the future of regulation, such as flavors in e-cigarettes, the effects of reducing nicotine in cigarettes, consumer perceptions of tobacco products, and addiction. CTP awarded 9 more grants in 2018 to fund further research on topics such as toxicity of tobacco smoke and aerosol, addiction, and the influences of tobacco marketing.

We developed a multi-year roadmap that places nicotine, and the issue of addiction, at the center of our tobacco regulation efforts.

We have a comprehensive framework to regulate nicotine to reduce the harm to society of tobacco use. In July 2017, the FDA announced a groundbreaking plan for tobacco and nicotine regulation. This plan acknowledges that some forms of nicotine delivery are potentially less harmful than others, with approved nicotine replacement therapies like patches or gum being the least harmful and combustible cigarettes being the deadliest.

Then in March 2018, the FDA issued an Advance Notice of Proposed Rulemaking for a product standard to lower nicotine levels in combusted cigarettes to minimally or non-addictive levels. This historic product standard could potentially prevent future generations from ever becoming addicted to the deadliest tobacco product, while making it easier for currently addicted cigarette smokers to quit.